Thus, the identification of endocytic activity as a novel effector function of MAP4K4 for migration and invasion control opens new conceptual avenues for tailored therapeutic interventions to selectively target metastatic tumor progression independent of the underlying oncogenic alteration. Here, MAP4K4 is linked to neoplasm.